MG ±ö¹û

Softgels are a versatile and scalable platform for pharmaceutical development with the ability to improve bioavailability, enhance patient compliance, and accommodate diverse formulations.

Learn how our proprietary expertise and proven techniques provide stable, integrated softgel solutions that achieve development goals.

Join our expert-led panel to explore innovative formulation strategies, the diverse mechanisms of action, preclinical and clinical considerations, as well as encapsulation techniques, and more.

Summary: Softgels are ideal for LBF delivery and are compatible with various formulations. Innovations like delayed release and plant-based capsules enhance drug delivery. LBFs with a Quality-by-Design approach offer an efficient route to market for complex drugs.

Learn how softgel capsules have advanced drug delivery by encapsulating a variety of active pharmaceutical ingredients (APIs).

Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.

Summary: This executive summary highlights lipid-based formulations (LBFs) in pharmaceutical development, emphasizing their complex composition and the critical role of careful formulation selection in the early stages of drug development.

Summary: This webinar explores formulation and manufacturing strategies, enriched by case studies on lipid-based drug delivery systems and softgels.

Summary: Unique combo formula containing LONGVIDA® Curcumin Extract intended to support joint comfort.

Summary: Leveraging MG ±ö¹û’s expert formulation and dose design capabilities, Kemin Industries has developed a new to the segment nutritional supplement which includes their proprietary phenolic complex Neumentixâ„¢ derived from spearmint.